Primary outcomes | Primary outcome variables |
Improvement in end-organ perfusion |
|
Mortality |
|
Secondary outcomes | Secondary outcome variables†|
Major neurosensory disability |
|
BPD Occurrence of adverse events | Adverse events
|
*The primary and secondary outcome variables are defined as per the primary studies.
†For all secondary outcome variables, the number or % in exposed versus unexposed groups; attributed to hydrocortisone will be applied for the analysis.
BPD, bronchopulmonary dysplasia; DBP, diastolic blood pressure; MBP, mean blood pressure; SBP, systolic blood pressure.